PSA screening reduces deaths by a fifth

The pro-PSA testing camp has been given a boost with a large randomised study showing it could reduce prostate cancer deaths by about a fifth.

However, the authors acknowledge over-diagnosis is a problem, with roughly 40% of positive tests proving to be false.

They conclude that introducing routine PSA screening now would be premature.

Despite the survival advantage, Professor Ian Olver, CEO of Cancer Council Australia,